
M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
Description
About M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
The M. tuberculosis Possible alanine rich dehydrogenase Peptide (IEDB: 144950) is a high quality epitope peptide for stimulation of antigen-specific T cells in T cell assays such as ELISPOT, ICS, cytotoxicity or proliferation assays. The Possible alanine rich dehydrogenase Peptide, H-RMPPLGHEL-OH (Uniprot: I6YAU3 aa: 170-178) from JPT is produced under strict quality control and quality management.
M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL - Specifications
- Peptide sequence: H-RMPPLGHEL-OH
- Amount: 1 mg
- Purity: Trial Grade: each peptide purified to > 90% (HPLC/MS)
- Counterion: TFA
- Delivery Format: Freeze-dried in glass vial
- Application(s): T-cell Immunity
- Condition(s)/Topic(s): Tuberculosis
- Standard Delivery Time: approx. 3 weeks
JPT’s Antigen Peptides
Find your antigen peptide and select the connected PepMix™ Peptide Pool for efficient immune monitoring, mapping of T cell epitopes or development of immunotherapy and vaccines. JPT Peptide Technologies has substantial, long-standing expertise in providing peptides, peptidomimetics, and proteins to the global scientific community. Our highly skilled and committed scientific staff ensures that the most appropriate methods and techniques are selected for every synthesis project. All our catalog peptides are provided with HPLC-MS analyses to confirm the identity and demonstrate the high quality of our peptides.
Not found what you are looking for? Take a look at our Custom Peptide Synthesis!
Benefits of JPT’s Antigen Peptides
- All peptides are made in Germany
- Bulk orders or custom peptide snythesis upon request
- Synthesis protocols designed to avoid toxic contaminants and side products
- Provision of freeze dried aliquots for enhanced stability
- Proven track record for applications in clinical studies
- Order the connected PepMix™ Peptide Pool with your peptide!
References
References for M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
References:
Read References with JPT’s Antigen Peptides
M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL has been described in:
Mycobacterium tuberculosis peptides presented by HLA-E molecules are targets for human CD8 T-cells with cytotoxic as well as regulatory activity., PLoS Pathog, 2010 (PMID: 20195504)
Human CD8+ T-cells recognizing peptides from Mycobacterium tuberculosis (Mtb) presented by HLA-E have an unorthodox Th2-like, multifunctional, Mtb inhibitory phenotype and represent a novel human T-cell subset., PLoS Pathog, 2015 (PMID: 25803478)
Mapping and role of T cell response in SARS-CoV-2-infected mice., J Exp Med, 2021 (PMID: 33464307)
Documentation
Documentation for M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
Properties
Properties of M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
Properties | Values |
---|---|
Application: | T-cell immunity |
Category: | Antigen Peptides |
Condition / Topic: | Tuberculosis |
Layout: | Freeze-dried in glass vial |
Organism: | M. tuberculosis |
Protein Name: | Possible alanine rich dehydrogenase |
Purity: | Trial Grade: each peptide purified to > 90% (HPLC/MS) |
Quantification: | No, Yes |
Further Information to M. tuberculosis Possible alanine rich dehydrogenase 170-178, RMPPLGHEL
Information | Values |
---|---|
Sequence: | H-RMPPLGHEL-OH |
Specifications: | 9mer peptide as TFA salt |